Mefenamic Acid: Fenamate NSAID, Dysmenorrhea, Short-Course Dosing and Safety
Evidence-informed pharmacology monograph updated 10 November 2026. Educational material; individualized treatment requires clinical assessment and current local prescribing information. Overview and chemical classification Mefenamic acid is an anthranilic acid-derived NSAID of the fenamate family, correctly named 2-[(2,3-dimethylphenyl)amino]benzoic acid. It reversibly inhibits cyclooxygenase COX-1 and COX-2, suppressing prostaglandin synthesis. The original monograph’s chemical name was inaccurate,…